Cargando…

Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling

Upper tract urothelial carcinoma (UTUC) is characterized by a distinctly aggressive clinical phenotype. To define the biological features driving this phenotype, we performed an integrated analysis of whole-exome and RNA sequencing of UTUC. Here we report several key insights from our molecular diss...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Brian D., Vlachostergios, Panagiotis J., Bhinder, Bhavneet, Liu, Weisi, Li, Kailyn, Moss, Tyler J., Bareja, Rohan, Park, Kyung, Tavassoli, Peyman, Cyrta, Joanna, Tagawa, Scott T., Nanus, David M., Beltran, Himisha, Molina, Ana M., Khani, Francesca, Miguel Mosquera, Juan, Xylinas, Evanguelos, Shariat, Shahrokh F., Scherr, Douglas S., Rubin, Mark A., Lerner, Seth P., Matin, Surena F., Elemento, Olivier, Faltas, Bishoy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611775/
https://www.ncbi.nlm.nih.gov/pubmed/31278255
http://dx.doi.org/10.1038/s41467-019-10873-y
_version_ 1783432760488099840
author Robinson, Brian D.
Vlachostergios, Panagiotis J.
Bhinder, Bhavneet
Liu, Weisi
Li, Kailyn
Moss, Tyler J.
Bareja, Rohan
Park, Kyung
Tavassoli, Peyman
Cyrta, Joanna
Tagawa, Scott T.
Nanus, David M.
Beltran, Himisha
Molina, Ana M.
Khani, Francesca
Miguel Mosquera, Juan
Xylinas, Evanguelos
Shariat, Shahrokh F.
Scherr, Douglas S.
Rubin, Mark A.
Lerner, Seth P.
Matin, Surena F.
Elemento, Olivier
Faltas, Bishoy M.
author_facet Robinson, Brian D.
Vlachostergios, Panagiotis J.
Bhinder, Bhavneet
Liu, Weisi
Li, Kailyn
Moss, Tyler J.
Bareja, Rohan
Park, Kyung
Tavassoli, Peyman
Cyrta, Joanna
Tagawa, Scott T.
Nanus, David M.
Beltran, Himisha
Molina, Ana M.
Khani, Francesca
Miguel Mosquera, Juan
Xylinas, Evanguelos
Shariat, Shahrokh F.
Scherr, Douglas S.
Rubin, Mark A.
Lerner, Seth P.
Matin, Surena F.
Elemento, Olivier
Faltas, Bishoy M.
author_sort Robinson, Brian D.
collection PubMed
description Upper tract urothelial carcinoma (UTUC) is characterized by a distinctly aggressive clinical phenotype. To define the biological features driving this phenotype, we performed an integrated analysis of whole-exome and RNA sequencing of UTUC. Here we report several key insights from our molecular dissection of this disease: 1) Most UTUCs are luminal-papillary; 2) UTUC has a T-cell depleted immune contexture; 3) High FGFR3 expression is enriched in UTUC and correlates with its T-cell depleted immune microenvironment; 4) Sporadic UTUC is characterized by a lower total mutational burden than urothelial carcinoma of the bladder. Our findings lay the foundation for a deeper understanding of UTUC biology and provide a rationale for the development of UTUC-specific treatment strategies.
format Online
Article
Text
id pubmed-6611775
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-66117752019-07-08 Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling Robinson, Brian D. Vlachostergios, Panagiotis J. Bhinder, Bhavneet Liu, Weisi Li, Kailyn Moss, Tyler J. Bareja, Rohan Park, Kyung Tavassoli, Peyman Cyrta, Joanna Tagawa, Scott T. Nanus, David M. Beltran, Himisha Molina, Ana M. Khani, Francesca Miguel Mosquera, Juan Xylinas, Evanguelos Shariat, Shahrokh F. Scherr, Douglas S. Rubin, Mark A. Lerner, Seth P. Matin, Surena F. Elemento, Olivier Faltas, Bishoy M. Nat Commun Article Upper tract urothelial carcinoma (UTUC) is characterized by a distinctly aggressive clinical phenotype. To define the biological features driving this phenotype, we performed an integrated analysis of whole-exome and RNA sequencing of UTUC. Here we report several key insights from our molecular dissection of this disease: 1) Most UTUCs are luminal-papillary; 2) UTUC has a T-cell depleted immune contexture; 3) High FGFR3 expression is enriched in UTUC and correlates with its T-cell depleted immune microenvironment; 4) Sporadic UTUC is characterized by a lower total mutational burden than urothelial carcinoma of the bladder. Our findings lay the foundation for a deeper understanding of UTUC biology and provide a rationale for the development of UTUC-specific treatment strategies. Nature Publishing Group UK 2019-07-05 /pmc/articles/PMC6611775/ /pubmed/31278255 http://dx.doi.org/10.1038/s41467-019-10873-y Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Robinson, Brian D.
Vlachostergios, Panagiotis J.
Bhinder, Bhavneet
Liu, Weisi
Li, Kailyn
Moss, Tyler J.
Bareja, Rohan
Park, Kyung
Tavassoli, Peyman
Cyrta, Joanna
Tagawa, Scott T.
Nanus, David M.
Beltran, Himisha
Molina, Ana M.
Khani, Francesca
Miguel Mosquera, Juan
Xylinas, Evanguelos
Shariat, Shahrokh F.
Scherr, Douglas S.
Rubin, Mark A.
Lerner, Seth P.
Matin, Surena F.
Elemento, Olivier
Faltas, Bishoy M.
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
title Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
title_full Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
title_fullStr Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
title_full_unstemmed Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
title_short Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
title_sort upper tract urothelial carcinoma has a luminal-papillary t-cell depleted contexture and activated fgfr3 signaling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611775/
https://www.ncbi.nlm.nih.gov/pubmed/31278255
http://dx.doi.org/10.1038/s41467-019-10873-y
work_keys_str_mv AT robinsonbriand uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT vlachostergiospanagiotisj uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT bhinderbhavneet uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT liuweisi uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT likailyn uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT mosstylerj uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT barejarohan uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT parkkyung uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT tavassolipeyman uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT cyrtajoanna uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT tagawascottt uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT nanusdavidm uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT beltranhimisha uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT molinaanam uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT khanifrancesca uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT miguelmosquerajuan uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT xylinasevanguelos uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT shariatshahrokhf uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT scherrdouglass uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT rubinmarka uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT lernersethp uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT matinsurenaf uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT elementoolivier uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling
AT faltasbishoym uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling